Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors.

Autor: Catalano M; Department of Health Science, University of Florence, Florence, 50134, Italy., Fancelli S; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy., Caliman E; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy., Mazzoni F; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy., Michelet MG; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Mancini S; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Manneschi C; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Shabani S; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Napolitano B; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Pillozzi S; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Roviello G; Department of Health Science, University of Florence, Florence, 50134, Italy. giandomenico.roviello@unifi.it.

Publikováno v: Scientific reports [Sci Rep] 2024 Nov 29; Vol. 14 (1), pp. 29655. Date of Electronic Publication: 2024 Nov 29.

Unconventional strategy could be the future: From target to KRAS broad range treatment.

Autor: Fancelli S; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy., Petroni G; Department of Experimental and Clinical Medicine, University of Florence, Italy., Pillozzi S; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Italy.

Publikováno v: Heliyon [Heliyon] 2024 Apr 18; Vol. 10 (9), pp. e29739. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406](S2059702922000278)(10.1016/j.esmoop.2022.100406)

Autor: Cantini L., Mentrasti G., Lo Russo G., Signorelli D., Pasello G., Rijavec E., Russano M., Antonuzzo L., Rocco D., Giusti R., Adamo V., Genova C., Tuzi A., Morabito A., Gori S., La Verde N., Chiari R., Cortellini A., Cognigni V., Pecci F., Indini A., De Toma A., Zattarin E., Oresti S., Pizzutilo E. G., Frega S., Erbetta E., Galletti A., Citarella F., Fancelli S., Caliman E., Della Gravara L., Malapelle U., Filetti M., Piras M., Toscano G., Zullo L., De Tursi M., Di Marino P., D'Emilio V., Cona M. S., Guida A., Caglio A., Salerno F., Spinelli G. P., Bennati C., Morgillo F., Russo A., Dellepiane C., Vallini I., Sforza V., Inno A., Rastelli F., Tassi V., Nicolardi L., Pensieri M. V., Emili R., Roca E., Migliore A., Galassi T., Rocchi M. B. L., Berardi R.

The publisher regrets that at the time the article was published the name of the author N. La Verde was mistakenly abbreviated as N.L. Verde. This has now been corrected. The publisher would like to apologise for any inconvenience caused.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::f1abf9e7d4b309d03a88d862cf6ffdee
http://hdl.handle.net/11588/881903

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Autor: Cantini L; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Labcorp Drug Development Inc, Princeton, NJ, USA., Paoloni F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Pecci F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Spagnolo F; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy., Genova C; Academic Medical Oncology Unit, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy., Tanda ET; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy., Aerts S; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Rebuzzi SE; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy.; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy., Fornarini G; Medical Oncology Unit 1, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy., Zoratto F; UOC Oncologia, Ospedale Santa Maria Goretti, Latina, Italy., Fancelli S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy., Lupi A; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Della Corte CM; Department of Precision Medicine, University of Campania, Italy., Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Bennati C; S Maria delle Croci Hospital, AUSL della Romagna, Ravenna, Italy., Ortega C; Oncology, Asl Cn2, Ospedale Michele e Pietro Ferrero, Verduno, Italy., Atzori F; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy., Piovano PL; Oncology Unit, Azienda Ospedaliera 'SS. Antonio e Biagio e C. Arrigo', Alessandria, Italy., Orciuolo C; Istituto di ricovero e cura a carattere scientific (IRCCS), National Cancer Institute Regina Elena, Rome, Italy., De Tursi M; Department of Innovative Technologies in Medicine and Dentistry, University G. D'Annunzio, Chieti-Pescara, Italy., Ghidini M; Oncology Unit, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy., Botticelli A; Medical Oncology Unit A, Policlinico Umberto I, Radiological, Oncological, Pathological Sciences Department, Sapienza University of Rome, Italy., Scagnoli S; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., Belluomini L; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Leporati R; Medical Oncology, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori, Milano, Italy., Veccia A; Medical Oncology, Santa Chiara Hospital, Largo Medaglie d'Oro 1, Trento, Italy., Di Giacomo AM; Center for Immuno-Oncology, University of Siena, University Hospital of Siena, Siena, Italy., Festino L; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione 'G. Pascale', Naples, Italy., Cortinovis D; SC Oncologia Medica ASST H S Gerardo, Monza, Italy., Acquati M; SC Oncologia Medica ASST H S Gerardo, Monza, Italy., Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di ricovero e cura a carattere scientific (IRCCS), Rome, Italy., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy., Tucci M; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy., Sergi MC; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy., Garutti M; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy., Puglisi F; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy.; Department of Medicine (DAME), University of Udine, Udine, Italy., Manglaviti S; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy., Citarella F; Department of Medical Oncology, Campus Bio-Medico University, Rome, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy., Rijavec E; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy., Lo Russo G; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy., Santini D; UOC Oncologia Medica Territoriale, Sapienza Università, Polo Pontino, Rome, Italy., Addeo A; Oncology Department, University Hospital Geneva, Geneva, Switzerland., Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology Unit, and Medical Oncology Unit, Careggi University Hospital, Florence, Italy., Indini A; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy., Rocchi MBL; Biomolecular Sciences Department, University of Urbino, Urbino, Italy., Cortellini A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Grossi F; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, University of insubria, Varese, Italy., Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione 'G. Pascale', Naples, Italy., Aerts JGJV; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Berardi R; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Jul 06; Vol. 115 (7), pp. 796-804.

EP17.06-01 COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study

Autor: Mentrasti, G., Cognigni, V., Galassi, T., Signorelli, D., Pizzutilo, E.G., Martinelli, F., Lo Russo, G., Leporati, R., Ambrosini, P., Giusti, R., D'Amuri, S., Rocco, D., Della Gravara, L., Antonuzzo, L., Fancelli, S., Gori, S., Sernia, S., Ferrari, M., De Tursi, M., Di Marino, P., Di Maio, M., Salerno, F., Zumstein, L., Russano, M., Citarella, F., Adamo, V., Russo, A., Scimone, C., Sforza, V., Morabito, A., La Verde, N., Cona, M.S., Catalano, V., Emili, R., Sarti, D., Morgillo, F., Di Guida, G., Rocchi, M.B.L., Parisi, A., Berardi, R.

Publikováno v: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S742-S743